Miconazolnitraat Teva

Miconazole nitrate, the active ingredient in Miconazolnitraat Teva, is a Azole antifungal presented as a topical formulation for skin application. It treats fungal skin infections such as athlete's foot, ringworm and yeast infections in adults and children. GNH USA supplies Miconazolnitraat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Miconazolnitraat Teva is an azole antifungal used to treat superficial fungal infections of the skin and related areas. - Tinea corporis: reduces redness, scaling and itching caused by ringworm of the body. - Tinea cruris: relieves inflammation and itching in the groin area caused by fungal infection. - Tinea pedis: clears athlete's foot symptoms including cracking and burning on the feet. - Candidiasis: eliminates cutaneous yeast overgrowth and associated irritation. - Seborrheic dermatitis: improves flaking and redness on scalp or face linked to Malassezia species.

Topical application of Miconazolnitraat Teva may cause local skin reactions.

Common Side Effects: - Burning sensation at the application site - Itching or mild irritation - Redness or erythema - Dryness or peeling of the skin - Pruritus surrounding the treated area

Serious or Rare Side Effects: - Severe contact dermatitis - Extensive skin ulceration - Allergic reaction with swelling or hives - Secondary bacterial infection of the treated area

Before using Miconazolnitraat Teva, consider the following safety measures. - Avoid use on extensive broken skin: limit application to intact epidermis. - Do not apply near eyes or mucous membranes: risk of irritation. - Discontinue if severe irritation or allergic reaction occurs: seek medical advice. - Keep the area clean and dry before application: enhances drug absorption. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Miconazolnitraat Teva may interact with other agents applied to the skin or absorbed systemically.

Major Interactions (Avoid): - Concurrent use of other topical azoles: may increase local irritation. - Systemic CYP450 inhibitors (e.g., ketoconazole oral): could raise systemic absorption risk.

Moderate Interactions (Monitor Closely): - Alcohol‑based topical products: may alter skin barrier and affect drug penetration. - Topical corticosteroids: can mask infection signs, delaying appropriate treatment. - Occlusive dressings: increase drug concentration and potential irritation.